7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Heart Failure and Transplant Cardiology
The management of heart failure has evolved significantly over the years, but for some patients, conventional treatments are not enough. Heart failure and transplant cardiology focus on advanced therapeutic interventions, including the use of ventricular assist devices (VADs) and heart transplantation. When heart failure reaches an advanced stage, a transplant may be the only option for survival, but this requires careful evaluation of the patient’s overall health and compatibility with a donor heart. Post-transplant care is equally crucial, involving immunosuppressive drugs to prevent rejection, as well as ongoing monitoring for complications. Innovations in both transplant techniques and alternative therapies like gene therapy and stem cell treatments are paving the way for improved outcomes in these patients, offering hope for those with end-stage heart failure.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya